Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 2/20 | 0.35 |
| ▸ | LPO | P22079 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | LGMN | Q99538 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1527275 | 0.82 | LMNA (0.40) | KDM4EMEN1KMT2AAR | |
| SCHEMBL28166008 | 0.81 | LMNA (0.39) | KDM4EMEN1KMT2AAR | |
| SCHEMBL19464477 | 0.72 | ALDH1A1 (0.53) | GAAALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL28298685 | 0.71 | ALDH1A1 (0.50) | GAAALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL23635700 | 0.69 | GAA (0.32) | GAAALDH1A1KDM4ESMN1; SMN2RECQL | |
| SCHEMBL30493068 | 0.69 | CRBN (0.36) | GAAALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL28207016 | 0.69 | ALDH1A1 (0.49) | GAAALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL30839880 | 0.69 | LMNA (0.39) | KDM4EMEN1KMT2AAR | |
| SCHEMBL8803221 | 0.69 | ALDH1A1 (0.45) | GAAALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL5222605 | 0.68 | IKBKB (0.33) | ARMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021143677-A1 | FUSED RING SUBSTITUTED AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND USE THEREOF | 青岛清原化合物有限公司 | 2021-07-22 | — | — | WO | disclosed |
| WO-2021139482-A1 | CARBOXYLIC ACID DERIVATIVE-SUBSTITUTED IMINO ARYL COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | 青岛清原化合物有限公司 | 2021-07-15 | — | — | WO | disclosed |
| US-6927193-B2 | Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2005-08-09 | — | — | US | disclosed |
| EP-0922570-B1 | Planographic printing plate precursor and a method for producing a planographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 2004-09-29 | — | — | EP | disclosed |
| EP-1432692-A1 | ARYL ETHER DERIVATIVES AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2004-06-30 | — | — | EP | disclosed |
| US-20030195118-A1 | Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them | ISHIHARA SANGYO KAISHA, LTD. | 2003-10-16 | — | — | US | disclosed |
| US-6613718-B2 | 2,3-Dihydro-2-thioxo-pyrimidinone derivatives | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2003-09-02 | — | — | US | disclosed |
| US-20030130122-A1 | Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them | ISHIHARA SANGYO KAISHA, LTD. | 2003-07-10 | — | — | US | disclosed |
| WO-2003029225-A1 | ARYL ETHER DERIVATIVES AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130122-A1 | Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them | CBR3, CBR1, DDT | GAA 3036/4885ALDH1A1 901/4885KDM4E 327/4885 |
| US-20030195118-A1 | Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them | CBR3, CBR1, DDT | GAA 3038/4885ALDH1A1 906/4885KDM4E 334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.